Cargando…
CD4 response, lipid changes and liver outcome in 506 patients receiving nevirapine-based regimens for a median of 9 years
Autores principales: | , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The International AIDS Society
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3113088/ http://dx.doi.org/10.1186/1758-2652-13-S4-P81 |
_version_ | 1782205885177659392 |
---|---|
author | Podzamczer, D Tiraboschi, JM Mallolas, J Cárdenes, MA Casas, E Castro, A Echevarria, S Leal, M Bernanldo de Quirós, JC Lopez Moreno, S Puig, T Ribera, E Villalonga, C Gomez Sirvent, JL Garcia Heranejos, JA Lopez-Aldeguer, J Barrufet, P Force, L Santos, I Sanz, J |
author_facet | Podzamczer, D Tiraboschi, JM Mallolas, J Cárdenes, MA Casas, E Castro, A Echevarria, S Leal, M Bernanldo de Quirós, JC Lopez Moreno, S Puig, T Ribera, E Villalonga, C Gomez Sirvent, JL Garcia Heranejos, JA Lopez-Aldeguer, J Barrufet, P Force, L Santos, I Sanz, J |
author_sort | Podzamczer, D |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-3113088 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2010 |
publisher | The International AIDS Society |
record_format | MEDLINE/PubMed |
spelling | pubmed-31130882011-06-13 CD4 response, lipid changes and liver outcome in 506 patients receiving nevirapine-based regimens for a median of 9 years Podzamczer, D Tiraboschi, JM Mallolas, J Cárdenes, MA Casas, E Castro, A Echevarria, S Leal, M Bernanldo de Quirós, JC Lopez Moreno, S Puig, T Ribera, E Villalonga, C Gomez Sirvent, JL Garcia Heranejos, JA Lopez-Aldeguer, J Barrufet, P Force, L Santos, I Sanz, J J Int AIDS Soc Poster Presentation The International AIDS Society 2010-11-08 /pmc/articles/PMC3113088/ http://dx.doi.org/10.1186/1758-2652-13-S4-P81 Text en Copyright ©2010 Podzamczer et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Poster Presentation Podzamczer, D Tiraboschi, JM Mallolas, J Cárdenes, MA Casas, E Castro, A Echevarria, S Leal, M Bernanldo de Quirós, JC Lopez Moreno, S Puig, T Ribera, E Villalonga, C Gomez Sirvent, JL Garcia Heranejos, JA Lopez-Aldeguer, J Barrufet, P Force, L Santos, I Sanz, J CD4 response, lipid changes and liver outcome in 506 patients receiving nevirapine-based regimens for a median of 9 years |
title | CD4 response, lipid changes and liver outcome in 506 patients receiving nevirapine-based regimens for a median of 9 years |
title_full | CD4 response, lipid changes and liver outcome in 506 patients receiving nevirapine-based regimens for a median of 9 years |
title_fullStr | CD4 response, lipid changes and liver outcome in 506 patients receiving nevirapine-based regimens for a median of 9 years |
title_full_unstemmed | CD4 response, lipid changes and liver outcome in 506 patients receiving nevirapine-based regimens for a median of 9 years |
title_short | CD4 response, lipid changes and liver outcome in 506 patients receiving nevirapine-based regimens for a median of 9 years |
title_sort | cd4 response, lipid changes and liver outcome in 506 patients receiving nevirapine-based regimens for a median of 9 years |
topic | Poster Presentation |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3113088/ http://dx.doi.org/10.1186/1758-2652-13-S4-P81 |
work_keys_str_mv | AT podzamczerd cd4responselipidchangesandliveroutcomein506patientsreceivingnevirapinebasedregimensforamedianof9years AT tiraboschijm cd4responselipidchangesandliveroutcomein506patientsreceivingnevirapinebasedregimensforamedianof9years AT mallolasj cd4responselipidchangesandliveroutcomein506patientsreceivingnevirapinebasedregimensforamedianof9years AT cardenesma cd4responselipidchangesandliveroutcomein506patientsreceivingnevirapinebasedregimensforamedianof9years AT casase cd4responselipidchangesandliveroutcomein506patientsreceivingnevirapinebasedregimensforamedianof9years AT castroa cd4responselipidchangesandliveroutcomein506patientsreceivingnevirapinebasedregimensforamedianof9years AT echevarrias cd4responselipidchangesandliveroutcomein506patientsreceivingnevirapinebasedregimensforamedianof9years AT lealm cd4responselipidchangesandliveroutcomein506patientsreceivingnevirapinebasedregimensforamedianof9years AT bernanldodequirosjclopez cd4responselipidchangesandliveroutcomein506patientsreceivingnevirapinebasedregimensforamedianof9years AT morenos cd4responselipidchangesandliveroutcomein506patientsreceivingnevirapinebasedregimensforamedianof9years AT puigt cd4responselipidchangesandliveroutcomein506patientsreceivingnevirapinebasedregimensforamedianof9years AT riberae cd4responselipidchangesandliveroutcomein506patientsreceivingnevirapinebasedregimensforamedianof9years AT villalongac cd4responselipidchangesandliveroutcomein506patientsreceivingnevirapinebasedregimensforamedianof9years AT gomezsirventjl cd4responselipidchangesandliveroutcomein506patientsreceivingnevirapinebasedregimensforamedianof9years AT garciaheranejosja cd4responselipidchangesandliveroutcomein506patientsreceivingnevirapinebasedregimensforamedianof9years AT lopezaldeguerj cd4responselipidchangesandliveroutcomein506patientsreceivingnevirapinebasedregimensforamedianof9years AT barrufetp cd4responselipidchangesandliveroutcomein506patientsreceivingnevirapinebasedregimensforamedianof9years AT forcel cd4responselipidchangesandliveroutcomein506patientsreceivingnevirapinebasedregimensforamedianof9years AT santosi cd4responselipidchangesandliveroutcomein506patientsreceivingnevirapinebasedregimensforamedianof9years AT sanzj cd4responselipidchangesandliveroutcomein506patientsreceivingnevirapinebasedregimensforamedianof9years |